For citations:
Ostroumova OD, Maksimov ML, Zamergrad MV, Parfenov VA, Zaharova EK, Vladykin AL, Globenko AA, Kapashin AV, Ishchenko KA. Evaluation of pharmacokinetic parameters, safety and tolerability of single and multiple doses of Vespireit®: results of phase I clinical trial. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(4):53-65. (In Russ.) https://doi.org/10.14412/2074-2711-2023-4-53-65
Email this article 